Royalty Pharma PLC's ticker is and the CUSIP is 00BMVP7Y0. A total of 1 filers reported holding Royalty Pharma PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,834,450 | +2.7% | 100,906 | -0.8% | 0.02% | -6.2% |
| Q3 2023 | $2,759,704 | -1.4% | 101,684 | +11.7% | 0.02% | 0.0% |
| Q2 2023 | $2,799,031 | -2.3% | 91,055 | +14.5% | 0.02% | -11.1% |
| Q1 2023 | $2,865,394 | +24.4% | 79,528 | +36.4% | 0.02% | +12.5% |
| Q4 2022 | $2,303,700 | -99.9% | 58,292 | +0.5% | 0.02% | -11.1% |
| Q3 2022 | $2,329,436,000 | -4.4% | 57,975 | 0.0% | 0.02% | +5.9% |
| Q2 2022 | $2,437,269,000 | -7.4% | 57,975 | -14.2% | 0.02% | +6.2% |
| Q1 2022 | $2,632,449,000 | +2.1% | 67,568 | +4.4% | 0.02% | +6.7% |
| Q4 2021 | $2,578,255,000 | +281.0% | 64,699 | +245.5% | 0.02% | +275.0% |
| Q3 2021 | $676,758,000 | -11.8% | 18,726 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $767,579,000 | +10.5% | 18,726 | +17.6% | 0.01% | 0.0% |
| Q1 2021 | $694,692,000 | – | 15,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DnB Asset Management AS | 57,975 | $2,329,436,000 | 0.02% |